| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| V Knott, A Labelle, B Jones, C Mahone. EEG hemispheric asymmetry as a predictor and correlate of short-term response to clozapine treatment in schizophrenia. Clinical EEG (electroencephalography). vol 31. issue 3. 2001-01-03. PMID:10923202. |
eeg hemispheric asymmetry as a predictor and correlate of short-term response to clozapine treatment in schizophrenia. |
2001-01-03 |
2023-08-12 |
Not clear |
| J T Birkett, M J Arranz, J Munro, S Osbourn, R W Kerwin, D A Collie. Association analysis of the 5-HT5A gene in depression, psychosis and antipsychotic response. Neuroreport. vol 11. issue 9. 2000-12-22. PMID:10884063. |
we conclude that allelic variation in the human 5-ht5a receptor gene may be involved in susceptibility to schizophrenia and affective disorders but not in determining response to clozapine. |
2000-12-22 |
2023-08-12 |
human |
| H Remschmidt, C Fleischhaker, K Hennighausen, E Schul. Management of schizophrenia in children and adolescents. The role of clozapine. Paediatric drugs. vol 2. issue 4. 2000-12-22. PMID:10946414. |
there are more than 15 studies that have also demonstrated the antipsychotic efficacy of clozapine in childhood and adolescent schizophrenia. |
2000-12-22 |
2023-08-12 |
Not clear |
| A Fink-Jense. Novel pharmacological approaches to the treatment of schizophrenia. Danish medical bulletin. vol 47. issue 3. 2000-11-30. PMID:10913983. |
these results are in accordance with the reported beneficial effects of clozapine, risperidone and sertindole on negative symptoms of schizophrenia and their lower degree of motoric side effects compared to haloperidol. |
2000-11-30 |
2023-08-12 |
human |
| A Fink-Jense. Novel pharmacological approaches to the treatment of schizophrenia. Danish medical bulletin. vol 47. issue 3. 2000-11-30. PMID:10913983. |
also these results are in concordance with the clinical effects of clozapine, risperidone, sertindole and haloperidol and support the hypothesis that reduced dopaminergic tone in the prefrontal cortex relates to the negative symptoms of schizophrenia. |
2000-11-30 |
2023-08-12 |
human |
| C A Buscema, Q A Abbasi, D J Barry, T H Lauv. An algorithm for the treatment of schizophrenia in the correctional setting: the Forensic Algorithm Project. The Journal of clinical psychiatry. vol 61. issue 10. 2000-11-30. PMID:11078038. |
the algorithm begins with any antipsychotic medication and proceeds to atypical neuroleptic usage, augmentation with other psychotropic agents, and, finally, the use of clozapine as the common pathway for refractory schizophrenia. |
2000-11-30 |
2023-08-12 |
Not clear |
| A Breier, R W Buchanan, D Irish, W T Carpente. Clozapine treatment of outpatients with schizophrenia: outcome and long-term response patterns. 1993. Psychiatric services (Washington, D.C.). vol 51. issue 10. 2000-11-07. PMID:11013322. |
clozapine treatment of outpatients with schizophrenia: outcome and long-term response patterns. |
2000-11-07 |
2023-08-12 |
Not clear |
| S M Dursun, A Szemis, H Andrews, P Whitaker, M A Revele. Effects of clozapine and typical antipsychotic drugs on plasma 5-HT turnover and impulsivity in patients with schizophrenia: a cross-sectional study. Journal of psychiatry & neuroscience : JPN. vol 25. issue 4. 2000-11-07. PMID:11022399. |
effects of clozapine and typical antipsychotic drugs on plasma 5-ht turnover and impulsivity in patients with schizophrenia: a cross-sectional study. |
2000-11-07 |
2023-08-12 |
Not clear |
| S A Chong, G Remingto. Clozapine augmentation: safety and efficacy. Schizophrenia bulletin. vol 26. issue 2. 2000-11-03. PMID:10885641. |
while clozapine has been demonstrated to be efficacious in refractory schizophrenia and possibly schizoaffective as well as bipolar disorders, a substantial number of patients still remain unresponsive. |
2000-11-03 |
2023-08-12 |
Not clear |
| R E Drake, H Xie, G J McHugo, A I Gree. The effects of clozapine on alcohol and drug use disorders among patients with schizophrenia. Schizophrenia bulletin. vol 26. issue 2. 2000-11-03. PMID:10885642. |
the effects of clozapine on alcohol and drug use disorders among patients with schizophrenia. |
2000-11-03 |
2023-08-12 |
human |
| R E Drake, H Xie, G J McHugo, A I Gree. The effects of clozapine on alcohol and drug use disorders among patients with schizophrenia. Schizophrenia bulletin. vol 26. issue 2. 2000-11-03. PMID:10885642. |
although not designed to assess clozapine, this study explored a posteriori the effects of clozapine on alcohol and drug use disorders among schizophrenia patients. |
2000-11-03 |
2023-08-12 |
human |
| R E Drake, H Xie, G J McHugo, A I Gree. The effects of clozapine on alcohol and drug use disorders among patients with schizophrenia. Schizophrenia bulletin. vol 26. issue 2. 2000-11-03. PMID:10885642. |
among 151 patients with schizophrenia or schizoaffective disorder and co-occurring substance use disorder who were studied in a dual-disorder treatment program, 36 received clozapine during the study for standard clinical indications. |
2000-11-03 |
2023-08-12 |
human |
| W T Carpenter, A Breier, R W Buchanan, B Kirkpatrick, P Shepard, E Weine. Mazindol treatment of negative symptoms. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. vol 23. issue 4. 2000-11-01. PMID:10989263. |
results for deficit and non-deficit schizophrenia subjects were similar, and were not affected by whether concurrent the antipsychotic drug treatment was clozapine, fluphenazine, or haloperidol. |
2000-11-01 |
2023-08-12 |
human |
| R Rosenheck, J Cramer, G Jurgis, D Perlick, W Xu, J Thomas, W Henderson, D Charne. Clinical and psychopharmacologic factors influencing family burden in refractory schizophrenia. The Department of Veterans Affairs Cooperative Study Group on Clozapine in Refractory Schizophrenia. The Journal of clinical psychiatry. vol 61. issue 9. 2000-10-25. PMID:11030488. |
the department of veterans affairs cooperative study group on clozapine in refractory schizophrenia. |
2000-10-25 |
2023-08-12 |
Not clear |
| R Rosenheck, J Cramer, G Jurgis, D Perlick, W Xu, J Thomas, W Henderson, D Charne. Clinical and psychopharmacologic factors influencing family burden in refractory schizophrenia. The Department of Veterans Affairs Cooperative Study Group on Clozapine in Refractory Schizophrenia. The Journal of clinical psychiatry. vol 61. issue 9. 2000-10-25. PMID:11030488. |
this study compares the effect of clozapine and haloperidol and identifies other factors related to family burden as experienced by relatives of patients with refractory schizophrenia (dsm-iii-r). |
2000-10-25 |
2023-08-12 |
Not clear |
| S J Tsai, C J Hong, Y W Yu, C H Lin, H L Song, H C Lai, K H Yan. Association study of a functional serotonin transporter gene polymorphism with schizophrenia, psychopathology and clozapine response. Schizophrenia research. vol 44. issue 3. 2000-10-11. PMID:10962219. |
the present study tested the hypothesis that a biallelic polymorphism in the 5' regulatory region of the 5-htt gene (5-httlpr) confers susceptibility to schizophrenia, association with the clinical manifestations of schizophrenia or clozapine response. |
2000-10-11 |
2023-08-12 |
Not clear |
| S J Tsai, C J Hong, Y W Yu, C H Lin, H L Song, H C Lai, K H Yan. Association study of a functional serotonin transporter gene polymorphism with schizophrenia, psychopathology and clozapine response. Schizophrenia research. vol 44. issue 3. 2000-10-11. PMID:10962219. |
the results demonstrated that the 5-httlpr variants did not play a major role in the susceptibility, clinical manifestations or clozapine response in schizophrenia. |
2000-10-11 |
2023-08-12 |
Not clear |
| A Schuld, M Kühn, M Haack, T Kraus, D Hinze-Selch, C Lechner, T Pollmäche. A comparison of the effects of clozapine and olanzapine on the EEG in patients with schizophrenia. Pharmacopsychiatry. vol 33. issue 3. 2000-10-02. PMID:10855462. |
a comparison of the effects of clozapine and olanzapine on the eeg in patients with schizophrenia. |
2000-10-02 |
2023-08-12 |
Not clear |
| A Schuld, M Kühn, M Haack, T Kraus, D Hinze-Selch, C Lechner, T Pollmäche. A comparison of the effects of clozapine and olanzapine on the EEG in patients with schizophrenia. Pharmacopsychiatry. vol 33. issue 3. 2000-10-02. PMID:10855462. |
we examined the eegs of patients with schizophrenia treated with either olanzapine (n = 9) or clozapine (n = 9) prior to medication and 3 to 7 weeks afterwards. |
2000-10-02 |
2023-08-12 |
Not clear |
| P M Llorca, C Lancon, J Farisse, J C Scott. Clozapine and negative symptoms. An open study. Progress in neuro-psychopharmacology & biological psychiatry. vol 24. issue 3. 2000-09-25. PMID:10836486. |
clozapine, the first atypical antipsychotic, has demonstrated an efficacy in the treatment of resistant schizophrenia. |
2000-09-25 |
2023-08-12 |
Not clear |